Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2021 Jun 5;1858(1):341. doi: 10.1007/s40278-021-97059-z

Remdesivir

Kidney disorder : case report

PMCID: PMC8178024

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

In a retrospective case-noncase study, conducted as pharmacovigilance analysis of 5532 ICSRs from VigiBase, a 68-year-old man from Australia 1 was described, who developed kidney disorder following treatment with remdesivir for COVID-19 [route, dosage, time to reaction onset and outcome not stated].

Footnotes

1

Identifiable patient's demographic details such as age, sex, and country was obtained from direct communication with the author.

Reference

  1. Chouchana L, et al. Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case-noncase study. Kidney International 99: 1235-1236, No. 5, May 2021. Available from: URL: 10.1016/j.kint.2021.02.015 [DOI] [PMC free article] [PubMed]

Articles from Reactions Weekly are provided here courtesy of Nature Publishing Group

RESOURCES